Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Nervous SystemDRG 094-bacterial-and-tuberculous-infections-of-nervous-system-with-mcc
    Ask Trek AI about this page

    Bacterial and Tuberculous Infections of Nervous System with MCC: Inpatient Reimbursement Overview

    DRG 094 addresses bacterial and tuberculous infections of the nervous system accompanied by Major Complication or Comorbidity; it captures high-acuity cases that demand intensive inpatient care. Correct DRG assignment affects Medicare payments because the Major Complication or Comorbidity designation increases expected resource intensity and reimbursement.

    Customize your policy alerts

    Sign up for drg 094 policy alerts

    Get alerted when payer policies referencing 094 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 094 Overview

    DRG 094 covers hospital admissions for bacterial and tuberculous infections of the nervous system that include a Major Complication or Comorbidity, such as severe sepsis, intracranial abscess with neurologic deterioration, or other life-threatening systemic complications. These cases typically require intensive medical management, prolonged antimicrobial therapy, potential neurosurgical intervention, and extended inpatient monitoring. This Diagnosis-Related Group is important for Medicare payment because the presence of a Major Complication or Comorbidity increases resource use and drives higher reimbursement relative to cases without such severity.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute antimicrobial therapy optimization trials: studies comparing different intravenous antibiotic regimens, dosing strategies, or duration of therapy for patients hospitalized with bacterial meningitis or tuberculous meningitis who present with severe manifestations and major complications (for example, sepsis, intracranial abscess, hydrocephalus, or need for ICU support). These trials enroll acutely ill adults and children within the inpatient setting to evaluate time to sterilization of cerebrospinal fluid, neurologic complication rates, and short-term mortality; results inform frontline clinicians about effective, rapid regimens and help payers assess cost-effectiveness of inpatient antimicrobial choices and lengths of stay. This research is relevant because prompt appropriate therapy and optimized dosing can reduce MCC-related morbidity, ICU utilization, and downstream costs associated with prolonged hospitalization and rehabilitation.
    • Comparative effectiveness studies of adjunctive interventions in complicated central nervous system infections: pragmatic trials or observational cohort studies testing adjunctive strategies such as corticosteroids, intracranial pressure management protocols, neurosurgical drainage techniques, or implementation of standardized sepsis pathways in patients with bacterial or tuberculous infections of the nervous system complicated by abscess, elevated intracranial pressure, or neurologic deterioration. These studies focus on heterogeneous inpatient populations with major complications to determine which adjuncts reduce neurologic sequelae, need for repeat surgery, or inpatient mortality, and they often measure resource use (ICU days, imaging, procedures) alongside clinical outcomes. Findings guide hospital protocols and resource allocation decisions important to providers managing complex cases and to payers evaluating value and reimbursement for bundled inpatient care.
    • Post-discharge functional outcomes and readmission prevention research: longitudinal cohort studies and intervention trials that follow survivors of severe CNS bacterial or tuberculous infections with major complications to evaluate rehabilitation needs, cognitive and functional recovery, rates and causes of 30- and 90-day readmissions, and the effectiveness of care-transition interventions (early outpatient follow-up, structured home health, or telemedicine monitoring). These studies enroll patients discharged after complicated inpatient courses and assess quality of life, long-term neurologic disability, and healthcare utilization; they are critical for designing post-acute care pathways, estimating long-term costs, and informing payers and providers about interventions that reduce readmissions and improve recovery trajectories for this high-risk DRG population.

    Related Codes

    020-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

    021-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-CC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

    022-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITHOUT-CC-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

    023-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITH-MCC-OR-ANTINEOPLASTIC-IMPLANT-OR-EPILEPSY-WITH-NEUROSTIMULATOR

    Craniotomy with Major Device Implant or Complex CNS DRG 023: Inpatient Reimbursement Overview

    024-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITHOUT-MCC

    Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC: Inpatient Reimbursement Overview

    025-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-MCC

    Craniotomy and Endovascular Intracranial Procedures with MCC: Inpatient Reimbursement Overview

    026-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-CC

    Craniotomy and Endovascular Intracranial Procedures with CC: Inpatient Reimbursement Overview

    027-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITHOUT-CC-MCC

    Craniotomy and Endovascular Intracranial Procedures without CC/MCC: Inpatient Reimbursement Overview

    028-SPINAL-PROCEDURES-WITH-MCC

    Spinal Procedures with MCC: Inpatient Reimbursement Overview

    029-SPINAL-PROCEDURES-WITH-CC-OR-SPINAL-NEUROSTIMULATORS

    Spinal Procedures with CC or Spinal Neurostimulators: Inpatient Reimbursement Overview

    Showing 1–10 of 71

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.